Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-01 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion · Option (right to buy) −60,000 0
2021-04-01 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion +50,000 $1.70 $85K 663,482
2021-04-01 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Sale −50,000 $23.00 $1.1M 613,482
2021-04-01 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Exercise or conversion · Option (right to buy) −50,000 50,000
2021-03-29 WYSZOMIERSKI JACK L Director Exercise or conversion +40,000 $3.38 $135K 237,809
2021-03-29 WYSZOMIERSKI JACK L Director Sale −6,220 $22.64 $141K 231,589
2021-03-29 WYSZOMIERSKI JACK L Director Exercise or conversion · Option (right to buy) −40,000 0
2021-03-15 Garber Alan M Director Exercise or conversion +40,000 $3.38 $135K 52,718
2021-03-15 Garber Alan M Director Sale −40,000 $23.60 $944K 12,718
2021-03-15 Garber Alan M Director Exercise or conversion · Option (right to buy) −40,000 0
2021-03-04 MORRISSEY MICHAEL President and CEO Grant or award · Option (right to buy) +494,700 494,700
2021-03-04 Schwab Gisela Pres, Prod Dev & Med Aff & CMO Grant or award +72,885 613,482
2021-03-04 Hessekiel Jeffrey EVP and General Counsel Grant or award +57,135 646,248
2021-03-04 Senner Christopher J. EVP and CFO Grant or award +64,150 356,591
2021-03-04 Haley Patrick J. EVP, Commercial Grant or award +59,570 305,057
2021-03-04 Lamb Peter EVP, Scientific Strategy & CSO Grant or award +49,395 389,467
2021-03-01 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion +65,000 $1.70 $111K 405,072
2021-03-01 Lamb Peter EVP, Scientific Strategy & CSO Sale −65,000 $22.11 $1.4M 340,072
2021-03-01 Lamb Peter EVP, Scientific Strategy & CSO Exercise or conversion · Option (right to buy) −65,000 60,000
2021-02-24 MORRISSEY MICHAEL President and CEO Gift −67,374 491,813

Page 34 of 42 · 836 trades